MyFinsight
Home
Blog
About
Back
Income Statement
SAB Biotherapeutics, Inc. (SABS)
SAB Biotherapeutics, Inc. (SABS)
source: myfinsight.com
Interest income
$1,709,000
(12501.39%↑ Y/Y)
Other income, net
$350,000
(18.39%↑ Y/Y)
Net gain
-$22,491,000
(-122.37%↓ Y/Y)
Total other income
(expense)
$886,000
(331.81%↑ Y/Y)
Changes in fair value of
warrant liabilities
$1,111,000
(77.18%↑ Y/Y)
Interest expense
$62,000
(-3.64%↓ Y/Y)
Loss from operations
-$23,377,000
(-140.21%↓ Y/Y)
Total operating
expenses
$23,377,000
(140.21%↑ Y/Y)
Research and development
$16,172,000
(131.14%↑ Y/Y)
General and
administrative
$7,205,000
(163.40%↑ Y/Y)
Back